OptimizeRx Earnings Preview
Portfolio Pulse from Benzinga Insights
OptimizeRx (NASDAQ:OPRX) is scheduled to release its quarterly earnings report on March 28, 2024, with analysts expecting an EPS of $0.26. The company's past earnings performance shows a mixed impact on its stock price, with the last quarter's beat resulting in a 1.23% drop. Shares are currently trading at $11.98, down 16.97% over the last year. Investors are keen on both the earnings outcome and the company's future guidance.
March 27, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
OptimizeRx is expected to announce its quarterly earnings with an anticipated EPS of $0.26. Historical data shows varied stock price reactions to earnings reports. Currently, shares are down 16.97% over the past year.
Given OptimizeRx's mixed historical earnings performance and the current downward trend in its stock price, the upcoming earnings report and future guidance will be crucial for investors. However, the impact of the earnings report on the stock price is uncertain, as past performance has shown varied reactions.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100